Antibody therapies for human immunodeficiency virus (HIV) Grant US-11845788-B2 United States of America 19 Dec 2023
Human immunodeficiency virus therapies utilizing N332-glycan-dependent antibodies in… Grant US-11202830-B2 United States of America 21 Dec 2021